Actavis has launched its generic version of AstraZeneca’s Pulmicort Respules after a US District Court judge in New Jersey denied AstraZeneca’s request for a permanent injunction and invalidated its patent.
Cumberland Pharmaceuticals has received clearance from the FDA to complete a study of Boxaban, which could be used to treat aspirin-exacerbated respiratory disease (AERD).
Theravance and Mylan will partner to develop and commercialize their COPD drug, TD-4208.
Celtaxsys, Inc, a clinical stage biotechnology company, announced that the FDA has granted orphan drug designation to its cystic fibrosis treatment drug leukotriene A4 hydrolase inhibitor.
With the full implementation of the Affordable Care Act, pulse oximetry is poised to play an even bigger role in helping hospitals achieve the end goal of reducing readmissions through patient monitoring.
Recent trends, such as the move toward home healthcare, have influenced new innovation in secretion clearance technology and will continue to shape this market in the future.
The use of Aerocrine’s FeNO-measuring device NIOX VERO as a tool for assessing patients with allergic airway inflammation has been cleared by Japanese health authorities.
Jaber Hassan, MD, of the Blount Memorial Sleep Health Center, says that recent advances in non-invasive ventilator support using BPAP or BiPAP systems have notably decreased patients’ with chronic obstructive pulmonary disease (COPD) chances of needing an invasive ventilator.
Capnia,Inc, has announced that it has submitted an application to the FDA to request Orphan Drug Designation for its nasal technology that treats trigeminal neuralgia.
Valeant Pharmaceuticals has recalled its antiviral drug Virazole, used to treat hospitalized infants and young children with severe lower respiratory tract infections due to RSV.
RT consulted leaders in patient monitoring technology to find out how pulse oximetry is evolving and how devices are improving chronic respiratory disease management.
Royal Philips has announced the European launch of the V680 ventilator for hospital respiratory care.
A smart watch for respiratory disease patients launched by Aseptika monitors the oxygen levels in patients' blood.
Lab Corp has announced the availability of a reflex test to identify EV-D68.
Sapheneia Inc and Scannerside have launched a single-source solution for CMS lung screening.
RT takes a look at some of the current offerings in the simulation sector, which are helping to test equipment and train novice and veteran respiratory care practitioners and improve quality of care.
Thanks to a new partnership with Microsoft, Aerocrine is exploring possibilities for its FeNO diagnostic medical devices to venture into the world of telemedicine.
ResMed has launched its new AirCurve 10 series, which includes three bilevel devices for to treat sleep apnea, and an adaptive servo-ventilation device for patients with central sleep apnea or Cheyne-Stokes respiration.
PulmoFlow Inc's Kitabis Pak, a co-packaging of generic tobramycin inhalation solution with a PARI LC PLUS Nebulizer, has been approved to treat cystic fibrosis.
A new study found that Anoro Ellipta ((umeclidinium /vilanterol) showed a statistically significant improvement in lung function compared with tiotropium for COPD patients.